Johnson's vaccinations have been suspended in the United States, the European Union and South Africa

 The U.S. Prothom-alo correspondent said there was concern among those who had received a single dose of the Johnson & Johnson vaccine. Although health workers say there is no reason to panic. The vaccine has been discontinued in all states since April 13. The supply of Pfizer and Modern is being increased in the vaccination centers.Those who have received the Johnson & Johnson vaccine have been asked to report any side effects to their respective physicians immediately.

The country's federal health agency announced on April 13 that it would suspend the use of Johnson & Johnson vaccines in the wake of rare blood clots in the bodies of six vaccinators. All six are women between the ages of 18 and 48.They develop problems within one to three weeks of receiving the vaccine. One of the women died and another was in critical condition at a Nebraska hospital.

 Health officials believe the Johnson & Johnson vaccine is so rare that it is not a problem for people to get vaccinated. However, they think that the hard-earned trust in the ticker will crack even a little bit.As a precautionary measure, Johnson & Johnson's vaccination has been suspended, but most people in the United States will be able to be vaccinated on time. The Federal Department of Health says the vaccination program will not be disrupted as a result. A statement from the White House said, "There is an adequate supply of Pfizer and modern vaccines and the target of 3 million vaccines per day will remain unchanged."According to the Centers for Disease Control and Prevention (CDC), about 6 million people in the United States have been vaccinated against Johnson & Johnson so far, and another 9 million doses have been sent to various states in the country.

Director of the Biological Evaluation and Research Center of the Department of Food and Drugs. Dr. Peter Marks and Chief Deputy Director of the Government Center for Disease Control and Prevention. "As a precautionary measure, we are stopping the use of this vaccine," Annie Schuchat said in a joint statement.At the moment, this negative reaction seems to be a very rare occurrence. '

Public health experts fear Johnson & Johnson's allegations of blood clots in the vaccine will further discourage those who are reluctant to take the vaccine from health authorities.

The Johnson & Johnson vaccine has also been suspended in the EU. The U.S. agency began vaccinating couLike Johnson & Johnson, the Oxford-AstraZeneca in the UK is in trouble in the European market. The same technology is used for both ticks. It uses mutated and harmless viruses. The use of the Oxford and AstraZeneca vaccines has resulted in very low blood clots in some countries. Since then, many countries have stopped using the vaccine. In some countries the vaccine is only given to older people.ntries in the EU this week.